| Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy MR Chappidi, M Kates, HD Patel, JJ Tosoian, DR Kaye, NA Sopko, ... Urologic oncology: seminars and original investigations 34 (6), 256. e1-256. e6, 2016 | 120 | 2016 |
| Prediction of pathological stage based on clinical stage, serum prostate‐specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era JJ Tosoian, M Chappidi, Z Feng, EB Humphreys, M Han, CP Pavlovich, ... BJU international 119 (5), 676-683, 2017 | 110 | 2017 |
| Prostate Health Index density improves detection of clinically significant prostate cancer JJ Tosoian, SC Druskin, D Andreas, P Mullane, M Chappidi, S Joo, ... BJU international 120 (6), 793-798, 2017 | 95 | 2017 |
| Cost-benefit analysis of a support program for nursing staff D Moran, AW Wu, C Connors, MR Chappidi, SK Sreedhara, JH Selter, ... Journal of Patient Safety 16 (4), e250-e254, 2020 | 86 | 2020 |
| Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice JJ Tosoian, SC Druskin, D Andreas, P Mullane, M Chappidi, S Joo, ... Prostate cancer and prostatic diseases 20 (2), 228-233, 2017 | 80 | 2017 |
| Oncological outcomes of sequential intravesical gemcitabine and docetaxel in patients with non-muscle invasive bladder cancer N Milbar, M Kates, MR Chappidi, F Pederzoli, T Yoshida, A Sankin, ... Bladder Cancer 3 (4), 293-303, 2017 | 78 | 2017 |
| Trends in red blood cell, plasma, and platelet transfusions in the United States, 1993-2014 R Goel, MR Chappidi, EU Patel, PM Ness, MM Cushing, SM Frank, ... Jama 319 (8), 825-827, 2018 | 60 | 2018 |
| Causes, timing, hospital costs and perioperative outcomes of index vs nonindex hospital readmissions after radical cystectomy: implications for regionalization of care MR Chappidi, M Kates, CJ Stimson, MH Johnson, PM Pierorazio, ... The Journal of urology 197 (2), 296-301, 2017 | 50 | 2017 |
| Prognostic utility of biopsy‐derived cell cycle progression score in patients with National Comprehensive Cancer Network low‐risk prostate cancer undergoing radical … JJ Tosoian, MR Chappidi, JT Bishoff, SJ Freedland, J Reid, M Brawer, ... BJU international 120 (6), 808-814, 2017 | 46 | 2017 |
| Quantifying nonindex hospital readmissions and care fragmentation after major urological oncology surgeries in a nationally representative sample MR Chappidi, M Kates, CJ Stimson, TJ Bivalacqua, PM Pierorazio The Journal of urology 197 (1), 235-240, 2017 | 41 | 2017 |
| Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A US population–based analysis (2004–2012) MR Chappidi, M Kates, MH Johnson, NM Hahn, TJ Bivalacqua, ... Urologic Oncology: Seminars and Original Investigations 34 (12), 531. e15 …, 2016 | 34 | 2016 |
| Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT? A Brant, M Kates, MR Chappidi, HD Patel, NA Sopko, GJ Netto, AS Baras, ... Urologic Oncology: Seminars and Original Investigations 35 (1), 34. e17-34. e25, 2017 | 33 | 2017 |
| Accuracy of urethral frozen section during radical cystectomy for bladder cancer M Kates, MW Ball, MR Chappidi, AS Baras, J Gordetsky, NA Sopko, ... Urologic Oncology: Seminars and Original Investigations 34 (12), 532. e1-532. e6, 2016 | 21 | 2016 |
| Implementation of a surgeon-level comparative quality performance review to improve positive surgical margin rates during radical prostatectomy RS Matulewicz, JJ Tosoian, CJ Stimson, AE Ross, M Chappidi, TL Lotan, ... The Journal of Urology 197 (5), 1245-1250, 2017 | 20 | 2017 |
| Thrombosis risk in cancer patients receiving red blood cell transfusions G Ramsey, PF Lindholm Seminars in thrombosis and hemostasis 45 (06), 648-656, 2019 | 18 | 2019 |
| Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology M Gupta, N Milbar, G Tema, F Pederzoli, M Chappidi, M Kates, ... World journal of urology 37, 2051-2058, 2019 | 17 | 2019 |
| Erectile dysfunction treatment following radical cystoprostatectomy: analysis of a nationwide insurance claims database MR Chappidi, M Kates, NA Sopko, GA Joice, JJ Tosoian, PM Pierorazio, ... The Journal of Sexual Medicine 14 (6), 810-817, 2017 | 17 | 2017 |
| Prognostic implications of prostatic urethral involvement in non-muscle-invasive bladder cancer A Brant, M Daniels, MR Chappidi, GA Joice, NA Sopko, A Matoso, ... World journal of urology 37, 2683-2689, 2019 | 16 | 2019 |
| Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States R Goel, EU Patel, JL White, MR Chappidi, PM Ness, MM Cushing, ... Transfusion 59 (2), 500-507, 2019 | 15 | 2019 |
| Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter? GA Joice, MR Chappidi, HD Patel, M Kates, NA Sopko, CJ Stimson, ... BJU international 122 (6), 1016-1024, 2018 | 12 | 2018 |
